Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
Nuvation Bio priced an upsized offering of $250 million in 0.75% Convertible Senior Notes due 2032, increasing the size from the previously announced $200 million. The company expects to receive approximately $241.2 million in net proceeds, which it will use to repay its senior secured loan agreement and fund general corporate purposes.
Key figures
- Deal Value Usd
- 250000000
- Offering Price
- 100
- Cap price
- 10.458
- Cap premium
- 80.0%
- Net proceeds
- 241200000
- Interest rate
- 0.75%
- Maturity date
- July 1, 2032
- Conversion premium
- 35.0%
- Over allotment size
- 37500000
- Initial conversion price
- 7.84
- Net proceeds with over allotment
- 277600000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.